The global Laparoscopy Devices Market is expected to grow steadily as hospitals, clinics, and surgical centers increase adoption of minimally invasive surgical technologies. According to the latest market analysis, the global laparoscopy devices market was valued at USD 9.04 billion in 2025 and is projected to grow from USD 9.73 billion in 2026 to USD 17.5 billion by 2034, registering a CAGR of 7.61% during 2026–2034.

Laparoscopy, also known as keyhole surgery, is a minimally invasive surgical method used to diagnose and treat abdominal and pelvic conditions. It involves small incisions through which laparoscopes and surgical instruments are inserted to visualize organs, perform biopsies, and conduct procedures such as cholecystectomy, appendectomy, anti-reflux surgery, bariatric surgery, and gynecological surgery.

Minimally Invasive Procedures Drive Market Growth

Growing preference for minimally invasive surgeries is one of the major factors supporting the laparoscopy devices market. Patients increasingly prefer laparoscopy over open surgery because it offers smaller incisions, reduced pain, lower bleeding risk, shorter hospital stays, faster recovery, and fewer post-operative complications.

Hospitals and surgical centers are also adopting laparoscopic procedures due to their precision, cost-effectiveness, and improved patient outcomes. Rising use of laparoscopy in general surgery, bariatric surgery, gynecology, urology, and colorectal procedures is expected to strengthen market demand.

Rising Colorectal Cancer Cases Support Device Adoption

The increasing incidence of colorectal cancer is another key growth driver. Laparoscopy devices are widely used in colorectal cancer surgeries for bowel resection and tumor removal while maintaining oncological safety.

These devices help surgeons perform procedures with better visualization, reduced trauma, and improved aesthetic results. Growing colorectal cancer cases, especially among younger adults in developed economies, are expected to increase demand for laparoscopic surgical solutions.

High Device and Procedure Costs Remain a Challenge

Despite strong adoption, the high cost of laparoscopic devices and procedures may restrict market growth. Robotic-assisted laparoscopic systems involve significant capital investment, maintenance costs, and specialized training requirements.

Limited access to robotic surgical platforms in developing regions also affects adoption. However, ongoing efforts to reduce robotic system costs and improve accessibility are expected to create long-term market opportunities.

Robot-Assisted Laparoscopy Creates New Opportunities

The rising adoption of robot-assisted laparoscopy is opening new growth opportunities for market players. Robotic systems help overcome limitations of traditional laparoscopic procedures by improving precision, flexibility, visualization, and surgeon control.

Robot-assisted laparoscopy is gaining traction in gynecological surgery, radical prostatectomy, partial nephrectomy, and complex abdominal procedures. As costs decline and technology becomes more accessible, adoption is expected to expand across hospitals and specialty clinics.

Energy Devices Lead the Product Segment

By product type, energy devices dominate the market. These devices are widely used for tissue cutting, coagulation, desiccation, and surgical precision during laparoscopic procedures.

Continuous technological advancements in energy-based surgical devices are improving procedure efficiency and reducing surgical variability. Growing demand for single-incision and advanced laparoscopic procedures is expected to support further segment growth.

General Surgery Remains the Largest Application Area

By application, general surgery holds the largest market share. Rising cases of gallbladder removal, hernia repair, appendectomy, and anti-reflux surgery are supporting demand for laparoscopy devices.

Bariatric surgery is also gaining momentum due to rising obesity rates and increasing use of laparoscopic procedures to manage obesity-related conditions such as type 2 diabetes, hypertension, high cholesterol, and sleep apnea.

Hospitals Dominate End-User Demand

By end-user, hospitals represent the largest segment due to widespread use of laparoscopy devices in operating rooms. Hospitals prefer laparoscopic surgery because it improves precision, lowers patient recovery time, and reduces overall hospitalization duration.

Clinics are also expected to grow rapidly as same-day surgical care, biopsy procedures, and cost-effective minimally invasive treatments gain popularity.

North America Holds the Largest Market Share

North America dominates the global laparoscopy devices market and is expected to grow at a CAGR of 5.5% during the forecast period. The region benefits from advanced healthcare infrastructure, rapid adoption of innovative surgical technologies, and growing use of robotic-assisted laparoscopy.

Rising morbid obesity cases and increasing demand for bariatric surgery are also contributing to market growth in the region.

Europe Emerges as the Fastest-Growing Region

Europe is expected to grow at a CAGR of 4.6% during the forecast period. The region has strong healthcare systems, advanced surgical facilities, and leading medical device companies specializing in laparoscopy and imaging technologies.

Germany, the UK, and France remain important markets due to rising demand for cost-effective and clinically efficient surgical solutions.

Asia-Pacific is also witnessing strong growth due to large patient populations, rising healthcare investment, and increasing demand for advanced laparoscopic procedures in China, India, Japan, South Korea, and Indonesia.

Key Market Players

Leading companies operating in the global laparoscopy devices market include:

• B. Braun Melsungen AG
• ConMed Corporation
• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic Plc.
• Karl Storz SE & Co. KG
• Richard Wolf GmbH
• Olympus Corporation
• Stryker Corporation

Recent Developments

In March 2023, Ronovo Surgical invited leading gynecological and urology surgeons to evaluate its Carina™ RAS Platform, a Chinese robotic-assisted surgery platform developed for laparoscopic procedures.

In February 2023, TELA Bio announced the U.S. commercial launch of two new OviTex® LPR device configurations for robotic and laparoscopic repair of large abdominal hernias.

Future Outlook

The laparoscopy devices market is expected to grow consistently through 2034 as demand rises for minimally invasive procedures, robotic-assisted surgery, advanced visualization, and precision-based surgical care. Companies investing in affordable robotic systems, improved energy devices, and advanced laparoscopic instruments are expected to strengthen their competitive position.

Explore the complete Laparoscopy Devices Market report to understand key trends, competitive insights, growth opportunities, and future forecasts.

https://straitsresearch.com/report/laparoscopy-devices-market

About Straits Research

Straits Research is a global market research and consulting firm delivering actionable business intelligence through comprehensive industry reports and customized research solutions. The company provides in-depth market analysis across healthcare, technology, chemicals, energy, automotive, food and beverages, and industrial sectors, helping organizations make informed strategic decisions through reliable data, expert insights, and future-focused market forecasts.